Showing results (401-410 of 2,902) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|May 27, 2017
An AAVP-based solid-phase transducing matrix for transgene delivery: potential for translational applicationsT L Smith, G R Souza, R L Sidman, et al.Cancer Gene Therapy|May 23, 2009
WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growthD E Zamora-Avila, P Zapata-Benavides, M A Franco-Molina, et al.Cancer Gene Therapy|May 23, 2009
Novel strategies to augment genetically delivered immunotoxin molecular therapy for cancer therapyX Liu, J Wu, S Zhang, et al.Cancer Gene Therapy|February 28, 2009
Suppression of N-Ras by shRNA-expressing plasmid increases sensitivity of HepG2 cells to vincristine-induced growth inhibitionH-x Sun, H-w He, S-h Zhang, et al.Cancer Gene Therapy|February 28, 2009
DNAzymes to mouse beta1 integrin mRNA in vivo: targeting the tumor vasculature and retarding cancer growthJ Niewiarowska, I Sacewicz, M Wiktorska, et al.Cancer Gene Therapy|December 20, 2008
Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cellsE-H Park, S S Koh, R Srisuttee, et al.Cancer Gene Therapy|January 24, 2009
P53 and PTEN expression contribute to the inhibition of EGFR downstream signaling pathway by cetuximabS Bouali, A-S Chrétien, C Ramacci, et al.Cancer Gene Therapy|January 24, 2009
Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2AO R F Mook, F Baas, M B de Wissel, et al.Cancer Gene Therapy|January 17, 2009
Tetracycline-inducible promoter-based conditionally replicative adenoviruses for the control of viral replicationH Zhang, K Takayama, L Zhang, et al.Cancer Gene Therapy|January 31, 2009
M-PEIs nanogels: potential nonviral vector for systemic plasmid delivery to tumor cellsL Dong, H Xu, Y-B Liu, et al.Pageof 291